Changes in MYD88 are associated with constitutive signaling through TLRs, contributing to the dysregulation of the NF-κB pathway and the development of an aggressive CLL phenotype [58,59]. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.